The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Biodurable Ocular Implant Market Research Report 2025

Global Biodurable Ocular Implant Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1731554

No of Pages : 93

Ask Your Query

Synopsis
Biodurable implants do not break down over time and may be removed or refilled once the treatment is complete.

Highlights
The global Biodurable Ocular Implant market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Biodurable Ocular Implant is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Biodurable Ocular Implant is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of Biodurable Ocular Implant include Glaukos Corp, Ocular Therapeutix, Santen Pharmaceutical, pSivida, Clearside Biomedical, Bausch Health, AptarGroup, Boehringer Ingelheim and Allergan, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for Biodurable Ocular Implant in Hospitals is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Anterior Drug Delivery Methods, which accounted for % of the global market of Biodurable Ocular Implant in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Biodurable Ocular Implant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biodurable Ocular Implant.
The Biodurable Ocular Implant market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Biodurable Ocular Implant market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biodurable Ocular Implant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

  • Glaukos Corp
  • Ocular Therapeutix
  • Santen Pharmaceutical
  • pSivida
  • Clearside Biomedical
  • Bausch Health
  • AptarGroup
  • Boehringer Ingelheim
  • Allergan
  • Re-Vana Therapeutics
  • PolyActiva
  • Genentech

Product Type Insights
Global markets are presented by Biodurable Ocular Implant type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Biodurable Ocular Implant are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Biodurable Ocular Implant segment by Type

  • Anterior Drug Delivery Methods
  • Posterior Drug Delivery Methods

Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Biodurable Ocular Implant market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Biodurable Ocular Implant market.
Biodurable Ocular Implant segment by Application

  • Hospitals
  • Clinics
  • Others

Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Biodurable Ocular Implant market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

  • This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biodurable Ocular Implant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
  • This report will help stakeholders to understand the global industry status and trends of Biodurable Ocular Implant and provides them with information on key market drivers, restraints, challenges, and opportunities.
  • This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
  • This report stays updated with novel technology integration, features, and the latest developments in the market
  • This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Biodurable Ocular Implant industry.
  • This report helps stakeholders to gain insights into which regions to target globally
  • This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biodurable Ocular Implant.
  • This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biodurable Ocular Implant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biodurable Ocular Implant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.

Index

1 Biodurable Ocular Implant Market Overview
1.1 Product Overview and Scope of Biodurable Ocular Implant
1.2 Biodurable Ocular Implant Segment by Type
1.2.1 Global Biodurable Ocular Implant Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Anterior Drug Delivery Methods
1.2.3 Posterior Drug Delivery Methods
1.3 Biodurable Ocular Implant Segment by Application
1.3.1 Global Biodurable Ocular Implant Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Biodurable Ocular Implant Market Size Estimates and Forecasts
1.4.1 Global Biodurable Ocular Implant Revenue 2017-2028
1.4.2 Global Biodurable Ocular Implant Sales 2017-2028
1.4.3 Biodurable Ocular Implant Market Size by Region: 2017 Versus 2021 Versus 2028
2 Biodurable Ocular Implant Market Competition by Manufacturers
2.1 Global Biodurable Ocular Implant Sales Market Share by Manufacturers (2017-2022)
2.2 Global Biodurable Ocular Implant Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Biodurable Ocular Implant Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Biodurable Ocular Implant Manufacturing Sites, Area Served, Product Type
2.5 Biodurable Ocular Implant Market Competitive Situation and Trends
2.5.1 Biodurable Ocular Implant Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Biodurable Ocular Implant Players Market Share by Revenue
2.5.3 Global Biodurable Ocular Implant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biodurable Ocular Implant Retrospective Market Scenario by Region
3.1 Global Biodurable Ocular Implant Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Biodurable Ocular Implant Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Biodurable Ocular Implant Market Facts & Figures by Country
3.3.1 North America Biodurable Ocular Implant Sales by Country
3.3.2 North America Biodurable Ocular Implant Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Biodurable Ocular Implant Market Facts & Figures by Country
3.4.1 Europe Biodurable Ocular Implant Sales by Country
3.4.2 Europe Biodurable Ocular Implant Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biodurable Ocular Implant Market Facts & Figures by Region
3.5.1 Asia Pacific Biodurable Ocular Implant Sales by Region
3.5.2 Asia Pacific Biodurable Ocular Implant Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Biodurable Ocular Implant Market Facts & Figures by Country
3.6.1 Latin America Biodurable Ocular Implant Sales by Country
3.6.2 Latin America Biodurable Ocular Implant Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Biodurable Ocular Implant Market Facts & Figures by Country
3.7.1 Middle East and Africa Biodurable Ocular Implant Sales by Country
3.7.2 Middle East and Africa Biodurable Ocular Implant Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Biodurable Ocular Implant Historic Market Analysis by Type
4.1 Global Biodurable Ocular Implant Sales Market Share by Type (2017-2022)
4.2 Global Biodurable Ocular Implant Revenue Market Share by Type (2017-2022)
4.3 Global Biodurable Ocular Implant Price by Type (2017-2022)
5 Global Biodurable Ocular Implant Historic Market Analysis by Application
5.1 Global Biodurable Ocular Implant Sales Market Share by Application (2017-2022)
5.2 Global Biodurable Ocular Implant Revenue Market Share by Application (2017-2022)
5.3 Global Biodurable Ocular Implant Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Glaukos Corp
6.1.1 Glaukos Corp Corporation Information
6.1.2 Glaukos Corp Description and Business Overview
6.1.3 Glaukos Corp Biodurable Ocular Implant Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Glaukos Corp Biodurable Ocular Implant Product Portfolio
6.1.5 Glaukos Corp Recent Developments/Updates
6.2 Ocular Therapeutix
6.2.1 Ocular Therapeutix Corporation Information
6.2.2 Ocular Therapeutix Description and Business Overview
6.2.3 Ocular Therapeutix Biodurable Ocular Implant Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Ocular Therapeutix Biodurable Ocular Implant Product Portfolio
6.2.5 Ocular Therapeutix Recent Developments/Updates
6.3 Santen Pharmaceutical
6.3.1 Santen Pharmaceutical Corporation Information
6.3.2 Santen Pharmaceutical Description and Business Overview
6.3.3 Santen Pharmaceutical Biodurable Ocular Implant Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Santen Pharmaceutical Biodurable Ocular Implant Product Portfolio
6.3.5 Santen Pharmaceutical Recent Developments/Updates
6.4 pSivida
6.4.1 pSivida Corporation Information
6.4.2 pSivida Description and Business Overview
6.4.3 pSivida Biodurable Ocular Implant Sales, Revenue and Gross Margin (2017-2022)
6.4.4 pSivida Biodurable Ocular Implant Product Portfolio
6.4.5 pSivida Recent Developments/Updates
6.5 Clearside Biomedical
6.5.1 Clearside Biomedical Corporation Information
6.5.2 Clearside Biomedical Description and Business Overview
6.5.3 Clearside Biomedical Biodurable Ocular Implant Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Clearside Biomedical Biodurable Ocular Implant Product Portfolio
6.5.5 Clearside Biomedical Recent Developments/Updates
6.6 Bausch Health
6.6.1 Bausch Health Corporation Information
6.6.2 Bausch Health Description and Business Overview
6.6.3 Bausch Health Biodurable Ocular Implant Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Bausch Health Biodurable Ocular Implant Product Portfolio
6.6.5 Bausch Health Recent Developments/Updates
6.7 AptarGroup
6.6.1 AptarGroup Corporation Information
6.6.2 AptarGroup Description and Business Overview
6.6.3 AptarGroup Biodurable Ocular Implant Sales, Revenue and Gross Margin (2017-2022)
6.4.4 AptarGroup Biodurable Ocular Implant Product Portfolio
6.7.5 AptarGroup Recent Developments/Updates
6.8 Boehringer Ingelheim
6.8.1 Boehringer Ingelheim Corporation Information
6.8.2 Boehringer Ingelheim Description and Business Overview
6.8.3 Boehringer Ingelheim Biodurable Ocular Implant Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Boehringer Ingelheim Biodurable Ocular Implant Product Portfolio
6.8.5 Boehringer Ingelheim Recent Developments/Updates
6.9 Allergan
6.9.1 Allergan Corporation Information
6.9.2 Allergan Description and Business Overview
6.9.3 Allergan Biodurable Ocular Implant Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Allergan Biodurable Ocular Implant Product Portfolio
6.9.5 Allergan Recent Developments/Updates
6.10 Re-Vana Therapeutics
6.10.1 Re-Vana Therapeutics Corporation Information
6.10.2 Re-Vana Therapeutics Description and Business Overview
6.10.3 Re-Vana Therapeutics Biodurable Ocular Implant Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Re-Vana Therapeutics Biodurable Ocular Implant Product Portfolio
6.10.5 Re-Vana Therapeutics Recent Developments/Updates
6.11 PolyActiva
6.11.1 PolyActiva Corporation Information
6.11.2 PolyActiva Biodurable Ocular Implant Description and Business Overview
6.11.3 PolyActiva Biodurable Ocular Implant Sales, Revenue and Gross Margin (2017-2022)
6.11.4 PolyActiva Biodurable Ocular Implant Product Portfolio
6.11.5 PolyActiva Recent Developments/Updates
6.12 Genentech
6.12.1 Genentech Corporation Information
6.12.2 Genentech Biodurable Ocular Implant Description and Business Overview
6.12.3 Genentech Biodurable Ocular Implant Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Genentech Biodurable Ocular Implant Product Portfolio
6.12.5 Genentech Recent Developments/Updates
7 Biodurable Ocular Implant Manufacturing Cost Analysis
7.1 Biodurable Ocular Implant Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biodurable Ocular Implant
7.4 Biodurable Ocular Implant Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biodurable Ocular Implant Distributors List
8.3 Biodurable Ocular Implant Customers
9 Biodurable Ocular Implant Market Dynamics
9.1 Biodurable Ocular Implant Industry Trends
9.2 Biodurable Ocular Implant Market Drivers
9.3 Biodurable Ocular Implant Market Challenges
9.4 Biodurable Ocular Implant Market Restraints
10 Global Market Forecast
10.1 Biodurable Ocular Implant Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biodurable Ocular Implant by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Biodurable Ocular Implant by Type (2023-2028)
10.2 Biodurable Ocular Implant Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biodurable Ocular Implant by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Biodurable Ocular Implant by Application (2023-2028)
10.3 Biodurable Ocular Implant Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biodurable Ocular Implant by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Biodurable Ocular Implant by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Biodurable Ocular Implant Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Biodurable Ocular Implant Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Biodurable Ocular Implant Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Biodurable Ocular Implant Market Competitive Situation by Manufacturers in 2021
Table 5. Global Biodurable Ocular Implant Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Biodurable Ocular Implant Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Biodurable Ocular Implant Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Biodurable Ocular Implant Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Biodurable Ocular Implant Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Biodurable Ocular Implant Manufacturing Sites and Area Served
Table 11. Manufacturers Biodurable Ocular Implant Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Biodurable Ocular Implant by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biodurable Ocular Implant as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Biodurable Ocular Implant Sales by Region (2017-2022) & (K Units)
Table 16. Global Biodurable Ocular Implant Sales Market Share by Region (2017-2022)
Table 17. Global Biodurable Ocular Implant Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Biodurable Ocular Implant Revenue Market Share by Region (2017-2022)
Table 19. North America Biodurable Ocular Implant Sales by Country (2017-2022) & (K Units)
Table 20. North America Biodurable Ocular Implant Sales Market Share by Country (2017-2022)
Table 21. North America Biodurable Ocular Implant Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Biodurable Ocular Implant Revenue Market Share by Country (2017-2022)
Table 23. Europe Biodurable Ocular Implant Sales by Country (2017-2022) & (K Units)
Table 24. Europe Biodurable Ocular Implant Sales Market Share by Country (2017-2022)
Table 25. Europe Biodurable Ocular Implant Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Biodurable Ocular Implant Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Biodurable Ocular Implant Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Biodurable Ocular Implant Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Biodurable Ocular Implant Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Biodurable Ocular Implant Revenue Market Share by Region (2017-2022)
Table 31. Latin America Biodurable Ocular Implant Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Biodurable Ocular Implant Sales Market Share by Country (2017-2022)
Table 33. Latin America Biodurable Ocular Implant Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Biodurable Ocular Implant Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Biodurable Ocular Implant Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Biodurable Ocular Implant Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Biodurable Ocular Implant Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Biodurable Ocular Implant Revenue Market Share by Country (2017-2022)
Table 39. Global Biodurable Ocular Implant Sales by Type (2017-2022) & (K Units)
Table 40. Global Biodurable Ocular Implant Sales Market Share by Type (2017-2022)
Table 41. Global Biodurable Ocular Implant Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Biodurable Ocular Implant Revenue Share by Type (2017-2022)
Table 43. Global Biodurable Ocular Implant Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Biodurable Ocular Implant Sales (K Units) by Application (2017-2022)
Table 45. Global Biodurable Ocular Implant Sales Market Share by Application (2017-2022)
Table 46. Global Biodurable Ocular Implant Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Biodurable Ocular Implant Revenue Share by Application (2017-2022)
Table 48. Global Biodurable Ocular Implant Price by Application (2017-2022) & (US$/Unit)
Table 49. Glaukos Corp Corporation Information
Table 50. Glaukos Corp Description and Business Overview
Table 51. Glaukos Corp Biodurable Ocular Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Glaukos Corp Biodurable Ocular Implant Product
Table 53. Glaukos Corp Recent Developments/Updates
Table 54. Ocular Therapeutix Corporation Information
Table 55. Ocular Therapeutix Description and Business Overview
Table 56. Ocular Therapeutix Biodurable Ocular Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Ocular Therapeutix Biodurable Ocular Implant Product
Table 58. Ocular Therapeutix Recent Developments/Updates
Table 59. Santen Pharmaceutical Corporation Information
Table 60. Santen Pharmaceutical Description and Business Overview
Table 61. Santen Pharmaceutical Biodurable Ocular Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Santen Pharmaceutical Biodurable Ocular Implant Product
Table 63. Santen Pharmaceutical Recent Developments/Updates
Table 64. pSivida Corporation Information
Table 65. pSivida Description and Business Overview
Table 66. pSivida Biodurable Ocular Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. pSivida Biodurable Ocular Implant Product
Table 68. pSivida Recent Developments/Updates
Table 69. Clearside Biomedical Corporation Information
Table 70. Clearside Biomedical Description and Business Overview
Table 71. Clearside Biomedical Biodurable Ocular Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Clearside Biomedical Biodurable Ocular Implant Product
Table 73. Clearside Biomedical Recent Developments/Updates
Table 74. Bausch Health Corporation Information
Table 75. Bausch Health Description and Business Overview
Table 76. Bausch Health Biodurable Ocular Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Bausch Health Biodurable Ocular Implant Product
Table 78. Bausch Health Recent Developments/Updates
Table 79. AptarGroup Corporation Information
Table 80. AptarGroup Description and Business Overview
Table 81. AptarGroup Biodurable Ocular Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. AptarGroup Biodurable Ocular Implant Product
Table 83. AptarGroup Recent Developments/Updates
Table 84. Boehringer Ingelheim Corporation Information
Table 85. Boehringer Ingelheim Description and Business Overview
Table 86. Boehringer Ingelheim Biodurable Ocular Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Boehringer Ingelheim Biodurable Ocular Implant Product
Table 88. Boehringer Ingelheim Recent Developments/Updates
Table 89. Allergan Corporation Information
Table 90. Allergan Description and Business Overview
Table 91. Allergan Biodurable Ocular Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Allergan Biodurable Ocular Implant Product
Table 93. Allergan Recent Developments/Updates
Table 94. Re-Vana Therapeutics Corporation Information
Table 95. Re-Vana Therapeutics Description and Business Overview
Table 96. Re-Vana Therapeutics Biodurable Ocular Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Re-Vana Therapeutics Biodurable Ocular Implant Product
Table 98. Re-Vana Therapeutics Recent Developments/Updates
Table 99. PolyActiva Corporation Information
Table 100. PolyActiva Description and Business Overview
Table 101. PolyActiva Biodurable Ocular Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. PolyActiva Biodurable Ocular Implant Product
Table 103. PolyActiva Recent Developments/Updates
Table 104. Genentech Corporation Information
Table 105. Genentech Description and Business Overview
Table 106. Genentech Biodurable Ocular Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Genentech Biodurable Ocular Implant Product
Table 108. Genentech Recent Developments/Updates
Table 109. Production Base and Market Concentration Rate of Raw Material
Table 110. Key Suppliers of Raw Materials
Table 111. Biodurable Ocular Implant Distributors List
Table 112. Biodurable Ocular Implant Customers List
Table 113. Biodurable Ocular Implant Market Trends
Table 114. Biodurable Ocular Implant Market Drivers
Table 115. Biodurable Ocular Implant Market Challenges
Table 116. Biodurable Ocular Implant Market Restraints
Table 117. Global Biodurable Ocular Implant Sales Forecast by Type (2023-2028) & (K Units)
Table 118. Global Biodurable Ocular Implant Sales Market Share Forecast by Type (2023-2028)
Table 119. Global Biodurable Ocular Implant Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 120. Global Biodurable Ocular Implant Revenue Market Share Forecast by Type (2023-2028)
Table 121. Global Biodurable Ocular Implant Sales Forecast by Application (2023-2028) & (K Units)
Table 122. Global Biodurable Ocular Implant Sales Market Share Forecast by Application (2023-2028)
Table 123. Global Biodurable Ocular Implant Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 124. Global Biodurable Ocular Implant Revenue Market Share Forecast by Application (2023-2028)
Table 125. Global Biodurable Ocular Implant Sales Forecast by Region (2023-2028) & (K Units)
Table 126. Global Biodurable Ocular Implant Sales Market Share Forecast by Region (2023-2028)
Table 127. Global Biodurable Ocular Implant Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 128. Global Biodurable Ocular Implant Revenue Market Share Forecast by Region (2023-2028)
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biodurable Ocular Implant
Figure 2. Global Biodurable Ocular Implant Market Share by Type in 2021 & 2028
Figure 3. Anterior Drug Delivery Methods Product Picture
Figure 4. Posterior Drug Delivery Methods Product Picture
Figure 5. Global Biodurable Ocular Implant Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Others
Figure 9. Global Biodurable Ocular Implant Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Biodurable Ocular Implant Market Size (2017-2028) & (US$ Million)
Figure 11. Global Biodurable Ocular Implant Sales (2017-2028) & (K Units)
Figure 12. Biodurable Ocular Implant Sales Share by Manufacturers in 2021
Figure 13. Global Biodurable Ocular Implant Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Biodurable Ocular Implant Players: Market Share by Revenue in 2021
Figure 15. Biodurable Ocular Implant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Biodurable Ocular Implant Sales Market Share by Region (2017-2022)
Figure 17. Global Biodurable Ocular Implant Sales Market Share by Region in 2021
Figure 18. Global Biodurable Ocular Implant Revenue Market Share by Region (2017-2022)
Figure 19. Global Biodurable Ocular Implant Revenue Market Share by Region in 2021
Figure 20. United States Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Colombia Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Turkey Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Saudi Arabia Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. UAE Biodurable Ocular Implant Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Sales Market Share of Biodurable Ocular Implant by Type (2017-2022)
Figure 44. Manufacturing Cost Structure of Biodurable Ocular Implant
Figure 45. Manufacturing Process Analysis of Biodurable Ocular Implant
Figure 46. Biodurable Ocular Implant Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock